Dalèle Elhani

Summary

Country: France

Publications

  1. ncbi [The widening challenge of extended spectrum β-lactamases]
    Dalèle Elhani
    Faculte de Pharmacie, Laboratoire des Maladies Transmissibles et Substances Biologiquement Actives, LR99ES27, Monastir, Tunisie
    Ann Biol Clin (Paris) 70:117-40. 2012
  2. ncbi [Dissemination of an extended spectrum beta-lactamase producing Klebsiella pneumoniae strains in a Tunisian university hospital center]
    D Elhani
    Laboratoire des Maladies Transmissibles et Substances Biologiquement Actives, Faculte de Pharmacie, Monastir, Tunisie
    Ann Biol Clin (Paris) 64:237-43. 2006
  3. ncbi Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains in a university hospital in Tunis, Tunisia, 1999-2005
    D Elhani
    Laboratoire des Maladies Transmissibles et Substances Biologiquement Actives, Faculte de Pharmacie, Monastir, Tunisie
    Clin Microbiol Infect 16:157-64. 2010
  4. ncbi [Does the emergence of antibiotic resistance announce the return of the dark ages?]
    Dalèle Elhani
    Faculte de Pharmacie, Laboratoire des Maladies Transmissibles et Substances Biologiquement Actives, LR99ES27, Monastir, Tunisie
    Ann Biol Clin (Paris) 69:637-46. 2011
  5. ncbi [The changing epidemiology of extended spectrum β-lactamase-producing Klebsiella pneumoniae]
    Dalèle Elhani
    Faculte de Pharmacie, Laboratoire des Maladies Transmissibles etSubstances Biologiquement Actives, LR99ES27, Monastir, Tunisie
    Ann Biol Clin (Paris) 69:523-9. 2011
  6. ncbi [Resistance in Gram negative bacteriae: what is the current situation?]
    Dalèle Elhani
    Laboratoire des Maladies Transmissibles et Substances Biologiquement Actives, Monastir, Tunisie
    Tunis Med 90:680-5. 2012

Collaborators

Detail Information

Publications6

  1. ncbi [The widening challenge of extended spectrum β-lactamases]
    Dalèle Elhani
    Faculte de Pharmacie, Laboratoire des Maladies Transmissibles et Substances Biologiquement Actives, LR99ES27, Monastir, Tunisie
    Ann Biol Clin (Paris) 70:117-40. 2012
    ....
  2. ncbi [Dissemination of an extended spectrum beta-lactamase producing Klebsiella pneumoniae strains in a Tunisian university hospital center]
    D Elhani
    Laboratoire des Maladies Transmissibles et Substances Biologiquement Actives, Faculte de Pharmacie, Monastir, Tunisie
    Ann Biol Clin (Paris) 64:237-43. 2006
    ..The used markers permitted the evaluation of a long-term strategy of prevention requiring a strict observance of hygiene rules and rational use of antibiotics...
  3. ncbi Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains in a university hospital in Tunis, Tunisia, 1999-2005
    D Elhani
    Laboratoire des Maladies Transmissibles et Substances Biologiquement Actives, Faculte de Pharmacie, Monastir, Tunisie
    Clin Microbiol Infect 16:157-64. 2010
    ....
  4. ncbi [Does the emergence of antibiotic resistance announce the return of the dark ages?]
    Dalèle Elhani
    Faculte de Pharmacie, Laboratoire des Maladies Transmissibles et Substances Biologiquement Actives, LR99ES27, Monastir, Tunisie
    Ann Biol Clin (Paris) 69:637-46. 2011
    ..It is only through the prudent use of antimicrobial drugs and the introduction of new and effective antibiotics that the antibiotic resistance will be slowed down and that we continue to treat bacterial infections...
  5. ncbi [The changing epidemiology of extended spectrum β-lactamase-producing Klebsiella pneumoniae]
    Dalèle Elhani
    Faculte de Pharmacie, Laboratoire des Maladies Transmissibles etSubstances Biologiquement Actives, LR99ES27, Monastir, Tunisie
    Ann Biol Clin (Paris) 69:523-9. 2011
    ..pneumoniae suggested the frequent transfer of this gene between different replicons. The acquisition of the bla(CTX-M-15) gene by K. pneumoniae was probably occurred via horizontal transfer from E. coli...
  6. ncbi [Resistance in Gram negative bacteriae: what is the current situation?]
    Dalèle Elhani
    Laboratoire des Maladies Transmissibles et Substances Biologiquement Actives, Monastir, Tunisie
    Tunis Med 90:680-5. 2012
    ....